MacroGenics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
MGNX Key Statistics
Stock Snapshot
MacroGenics(MGNX) stock is priced at $1.51, giving the company a market capitalization of 95.2M. It carries a P/E multiple of -1.24.
During the trading session on 2025-11-14, MacroGenics(MGNX) shares reached a daily high of $1.61 and a low of $1.49. At a current price of $1.51, the stock is +1.7% higher than the low and still -5.9% under the high.
Trading activity shows a volume of 1.8M, compared to an average daily volume of 927.52K.
Over the past 52 weeks, MacroGenics(MGNX) stock has traded between a high of $3.84 and a low of $0.99.
Over the past 52 weeks, MacroGenics(MGNX) stock has traded between a high of $3.84 and a low of $0.99.
MGNX News
TD Cowen analyst Tara Bancroft has maintained their neutral stance on MGNX stock, giving a Hold rating today. Meet Your ETF AI Analyst Discover how TipRanks' ET...
Reports Q3 revenue $72.839M vs $110.7M last year. “During the third quarter, our team aggressively advanced each of our previously outlined strategic priorities...
Cash Runway Guidance: MacroGenics (MGNX) anticipates that its cash, cash equivalents and marketable securities balance of $146.4 million as of September 30, 202...